CBD is really a CB1 antagonist which has a weak affinity for that CB1 receptor, which means it doesn’t bind quite strongly. From the pharmacological standpoint, it’s very similar to THC, and also the very constrained exploration that has been accomplished on it indicates it has comparable consequences, just with https://thcdisposables.co.uk/